EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Role of Gut Microbiome in Oncogenesis and Oncotherapies

Renuka Sri Sai Peddireddi iD, Sai Kiran Kuchana, Rohith Kode, Saketh Khammammettu, Aishwarya Koppanatham iD, Supriya Mattigiri, Harshavardhan Gobburi iD, Suresh K Alahari iD

Cancers · 29.12.2025 · 18 (1) · 99

DOI: 10.3390/cancers18010099 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 29.12.2025. Verfasst von Renuka Sri Sai Peddireddi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Mansfield Kaseman Health Clinic, Rockville, MD 20850, USA. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut microbiome has emerged as a key regulator of human health, influencing not only metabolism and immunity but also the development and treatment of cancer. Mounting evidence suggests that microbial dysbiosis contributes to oncogenesis by driving chronic inflammation, producing genotoxic metabolites, altering bile acid metabolism, and disrupting epithelial barrier integrity. At the same time, the gut microbiome significantly modulates the host response to oncotherapies including chemotherapy, radiotherapy, and especially immunotherapy, where microbial diversity and specific taxa determine treatment efficacy and toxicity. This review synthesizes current evidence on the role of the gut microbiome in both oncogenesis and oncotherapies, focusing on thirteen cancers with the strongest and most clinically relevant microbiome associations, colorectal cancer, gastric cancer, hepatocellular carcinoma, gallbladder cancer, esophageal cancer, pancreatic cancer, oral squamous cell carcinoma, cervical cancer, prostate cancer, breast cancer, lung cancer, brain cancer, and melanoma. These cancers were selected based on robust mechanistic data linking microbial alterations to tumor initiation, progression, and therapy modulation, as well as their global health burden and translational potential. In addition, we have provided mechanistic insights or clinical correlations between the microbiome and cancer outcomes. Across cancers, common microbial mechanisms included pro-inflammatory signaling (e.g., NF-κB and STAT3 pathways), DNA damage from bacterial toxins (e.g., colibactin, nitrosating species), and metabolite-driven tumor promotion (e.g., secondary bile acids, trimethylamine N-oxide). Conversely, beneficial commensals such as Faecalibacterium prausnitzii and Akkermansia muciniphila supported antitumor immunity and improved responses to immune checkpoint inhibitors. In conclusion, the gut microbiome functions as both a driver of malignancy and a modifiable determinant of therapeutic success. Integrating microbiome profiling and modulation strategies such as dietary interventions, probiotics, and fecal microbiota transplantation into oncology practice may pave the way for personalized and more effective cancer care.

Schlagwörter

Stichwörter der Autor:innen

cancer immunotherapydysbiosisfecal microbiota transplantation (FMT)gut microbiomeoncogenesisoncotherapyprobiotics

Autor:innen und Institutionen

  • Mansfield Kaseman Health Clinic, Rockville, MD 20850, USA.
  • Department of Internal Medicine, Kakatiya Medical College, Warangal 506007, India.
  • Apollo Institute of Medical Sciences and Research, Hyderabad 500096, India.
  • Andhra Medical College, Visakhapatnam 530002, India.
  • Katuri Medical College and Hospital, Guntur 522019, India.
  • Department of Internal Medicine, Osmania Medical College, Hyderabad 500095, India.

ORCID-Profile: Renuka Sri Sai Peddireddi, Aishwarya Koppanatham, Harshavardhan Gobburi, Suresh K Alahari

Zitieren

APA

Peddireddi, R. S. S., Kuchana, S. K., Kode, R., Khammammettu, S., Koppanatham, A., Mattigiri, S., Gobburi, H., & Alahari, S. K. (2025). Role of Gut Microbiome in Oncogenesis and Oncotherapies. Cancers, 18(1), 99. https://doi.org/10.3390/cancers18010099

Vancouver

Peddireddi RSS, Kuchana SK, Kode R, Khammammettu S, Koppanatham A, Mattigiri S, et al. Role of Gut Microbiome in Oncogenesis and Oncotherapies. Cancers. 2025;18(1):99. doi:10.3390/cancers18010099

BibTeX
@article{Peddireddi2025,
  author = {Peddireddi, Renuka Sri Sai and Kuchana, Sai Kiran and Kode, Rohith and Khammammettu, Saketh and Koppanatham, Aishwarya and Mattigiri, Supriya and Gobburi, Harshavardhan and Alahari, Suresh K},
  title = {Role of Gut Microbiome in Oncogenesis and Oncotherapies},
  journal = {Cancers},
  year = {2025},
  volume = {18},
  number = {1},
  pages = {99},
  doi = {10.3390/cancers18010099}
}
Kostenlos starten →